Fundz

Otolith Labs Appoints Kevin Franck as Chief Clinical Officer

PRIVATEMay 07, 2024

Position

Chief Clinical Officer

Company

Otolith Labs

Kevin Franck
kevin@otolithlabs.com
WashingtonBiotechnologyHealthcareHealth CareMedicalMedical Device

Description

Otolith Labs, a medical technology company specializing in non-invasive wearable medical devices for the treatment of vestibular disorders, has appointed Kevin Franck, PhD, MBA as its Chief Clinical Officer. Dr. Franck will oversee the clinical and regulatory strategy and play a vital role in developing and executing clinical studies for FDA submission and the go-to-market strategy.

Quick answer

Otolith Labs Appoints Kevin Franck as Chief Clinical Officer (May 7, 2024). Otolith Labs is based in Washington, District Of Columbia, United States.

Who is the new Chief Clinical Officer at Otolith Labs?
Otolith Labs named Kevin Franck Chief Clinical Officer, announced May 7, 2024.
What did Otolith Labs announce on May 7, 2024?
Otolith Labs, a medical technology company specializing in non-invasive wearable medical devices for the treatment of vestibular disorders, has appointed Kevin Franck, PhD, MBA as its Chief Clinical Officer. Dr. Franck will oversee the clinical and regulatory strategy and play a vital role in developing and executing clinical studies for FDA submission and the go-to-market strategy.
What does Otolith Labs do?
Otolith Labs is developing prescription medical devices for the treatment of vestibular disorders, conditions experienced by millions of Americans.
Where is Otolith Labs based?
Otolith Labs is based in Washington, District Of Columbia, United States.
Which similar companies made leadership changes around the same time?
Sanara MedTech (April 5, 2024), RIVANNA (March 29, 2024), Nevro (May 7, 2024) and Odysight.ai (May 6, 2024) also announced leadership changes within 45 days of Otolith Labs.

Source: Fundz verified event record.

Other recent leadership changes in Healthcare and Medical

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Otolith Labs, and when

A new leader at Otolith Labs brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Otolith Labs raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Otolith Labs, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Otolith Labs. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Otolith Labs

Location

Massachusetts Ave Nw

Washington, District Of Columbia, United States

About

Otolith Labs is developing prescription medical devices for the treatment of vestibular disorders, conditions experienced by millions of Americans. Its flagship product, a patented noninvasive Vestibular System Masking (nVSM) technology, is intended to be the first prescription wearable device for the treatment of chronic vertigo, a symptom that affects more than 4 million Americans. The device, whichreceived Breakthrough Device Designation from the FDA, uses precisely tuned vibrations to interact with the acceleration sensors in the inner ear, mitigating the symptoms of vertigo. Otolith is conducting clinical trials to evaluate its nVSM technology as an immediate symptom relief treatment for chronic vertigo associated with vestibular disorders.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Otolith Labs changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Samuel
Senior decision-maker at this company
••••••••@••••••••

See Samuel's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Otolith Labs's next move

Learn about Strategic plan

Otolith Labs changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.